Issues related to health insurance price transparency. Issues related to prescription drug costs and delivery. Issues related to Surprise Billing.
2026 · 3rd Quarter (July 1 - Sep 30)
ELEVANCE HEALTH, INC.
Filed by MEHLMAN CONSULTING, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- $90,000.00
- Expenses
- Not reported
- Registrant
- MEHLMAN CONSULTING, INC.
- Client
- ELEVANCE HEALTH, INC.
- Filing UUID
- 36f28c85-fb8b-48fd-8a60-4c1b6a813382
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Medicare Advantage, Medicare Part D, Medicaid Managed Care. Issues related to prescription drug costs and delivery. PBM Reform issues. CY 2027 Medicare Advantage Rate Notice. S. 1105 - No UPCODE Act. H.R. 5243 - To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage. H.R. 4093 - Apples to Apples Comparison Act of 2026.
Literal federal measure citations: S. 1105, H.R. 5243, H.R. 4093
Prescription Drug Pricing.
Issues related to tax-preferred accounts to help lower the cost of insurance.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.